These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 15269929)

  • 1. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hospital and community pharmacists in pharmacovigilance.
    van Grootheest AC; de Jong-van den Berg LT
    Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
    Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
    Blenkinsopp A; Wilkie P; Wang M; Routledge PA
    Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?
    Walji R; Boon H; Barnes J; Welsh S; Austin Z; Baker GR
    Int J Pharm Pract; 2011 Dec; 19(6):383-91. PubMed ID: 22060233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-managed monitoring of adverse reactions to contrast media.
    Damiani DR; Swanson DP
    Am J Hosp Pharm; 1994 Feb; 51(3):358-63. PubMed ID: 8160688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous reporting of adverse drug reactions by nurses.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot study.
    van Grootheest AC; Groote JK; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):475-81. PubMed ID: 14513661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting.
    Christensen ST; Søndergaard B; Honoré PH; Bjerrum OJ
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):399-404. PubMed ID: 21442686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of Pharmacovigilance Centres in medication errors detection: a questionnaire-based analysis.
    Benabdallah G; Benkirane R; Khattabi A; Edwards IR; Bencheikh RS
    Int J Risk Saf Med; 2011; 23(1):17-29. PubMed ID: 21507783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the pharmacist in reporting adverse drug reactions in the emergency department.
    Ratz Y; Shafir I; Berkovitch S; Sharristh M; Jacoby M; Kozer E; Golik A; Berkovitch M; Bar-Haim S
    J Clin Pharmacol; 2010 Oct; 50(10):1217-21. PubMed ID: 20418507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.